...
【24h】

Personalized Medicine for Sepsis

机译:个性化脓毒症药物

获取原文
获取原文并翻译 | 示例

摘要

Sepsis is a complex syndrome triggered by infection and characterized by systemic deregulation of immune and inflammatory pathways. It is a major cause of death worldwide and results in the widespread use of antibiotics and substantial health care costs. In a vicious circle, sepsis treatment promotes the emergence of highly virulent and resistant pathogens and devastating nosocomial infections. Sepsis is a heterogeneous disease affecting many people worldwide. Because individual patients have different inflammatory responses and unique profiles of immune activation against pathogens, the most effective way to advance the treatment of sepsis is probably through a tailored approach. The advent of high-throughput technologies and the remarkable progress in the field of bioinformatics has allowed the subclassification of many pathological conditions. This has potential to provide better understanding of life-threatening infections in people. The study of host factors, however, needs to be integrated with studies on bacterial signaling in both symbiotic and pathogenic bacteria. Sepsis is certainly the sum of multiple host-microbial interactions and the metagenome should be extensively investigated. Personalized medicine is probably the only strategy able to deconstruct and reassemble our knowledge about sepsis, and its use should allow us to understand and manipulate sepsis as a wide, interconnected phenomenon with myriad variables and peculiarities. In this study, the recent advances in this area, the major challenges that remain, and the reasons why the septic patient should be approached as a superorganism are discussed.
机译:败血症是由感染触发的复杂综合征,其特征在于免疫和炎症途径的系统性失调。它是全世界死亡的主要原因,并导致抗生素的广泛使用和大量的医疗费用。在一个恶性循环中,败血症治疗促进了高毒力和耐药性病原体的出现,并破坏了医院内的感染。败血症是一种异质性疾病,影响全世界许多人。由于个别患者具有不同的炎症反应和针对病原体的免疫激活的独特特征,因此推进败血症治疗的最有效方法可能是通过量身定制的方法。高通量技术的出现和生物信息学领域的显着进步已使许多病理状况得以细分。这有可能使人们更好地了解威胁生命的感染。然而,宿主因素的研究需要与共生和致病细菌中细菌信号的研究相结合。脓毒症当然是多种宿主-微生物相互作用的总和,并且应该对该基因组进行广泛研究。个性化医学可能是唯一能够解构和重组我们对败血症知识的策略,并且其使用应使我们能够将败血症理解为具有多种变量和特点的广泛,相互联系的现象。在这项研究中,讨论了该领域的最新进展,仍然存在的主要挑战以及将败血症患者作为超生物体接触的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号